vasopressin in 0.9% sodium chloride

Generic: vasopressin in 0.9% sodium chloride

Labeler: baxter healthcare corporation
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name vasopressin in 0.9% sodium chloride
Generic Name vasopressin in 0.9% sodium chloride
Labeler baxter healthcare corporation
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

vasopressin 20 [USP'U]/100mL

Manufacturer
Baxter Healthcare Corporation

Identifiers & Regulatory

Product NDC 0338-9640
Product ID 0338-9640_e5fb5b63-6f2e-4ebe-9a55-147a793e95dd
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA217569
Listing Expiration 2026-12-31
Marketing Start 2023-09-29

Pharmacologic Class

Chemical Structure
vasopressins [cs]
Physiologic Effect
vasoconstriction [pe] decreased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 03389640
Hyphenated Format 0338-9640

Supplemental Identifiers

RxCUI
2399907 2591428
UNII
Y4907O6MFD
NUI
M0022562 N0000009908 N0000175360

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vasopressin in 0.9% sodium chloride (source: ndc)
Generic Name vasopressin in 0.9% sodium chloride (source: ndc)
Application Number NDA217569 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 20 [USP'U]/100mL
source: ndc
Packaging
  • 12 BAG in 1 CARTON (0338-9640-12) / 100 mL in 1 BAG
source: ndc

Packages (1)

Ingredients (1)

vasopressin (20 [USP'U]/100mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "e5fb5b63-6f2e-4ebe-9a55-147a793e95dd", "openfda": {"nui": ["M0022562", "N0000009908", "N0000175360"], "unii": ["Y4907O6MFD"], "rxcui": ["2399907", "2591428"], "spl_set_id": ["b5b2c367-6b7e-40be-a296-c4632f3e783f"], "pharm_class_cs": ["Vasopressins [CS]"], "pharm_class_pe": ["Vasoconstriction [PE]", "Decreased Diuresis [PE]"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "12 BAG in 1 CARTON (0338-9640-12)  / 100 mL in 1 BAG", "package_ndc": "0338-9640-12", "marketing_start_date": "20230929"}], "brand_name": "Vasopressin in 0.9% Sodium Chloride", "product_id": "0338-9640_e5fb5b63-6f2e-4ebe-9a55-147a793e95dd", "dosage_form": "INJECTION", "pharm_class": ["Decreased Diuresis [PE]", "Vasoconstriction [PE]", "Vasopressins [CS]"], "product_ndc": "0338-9640", "generic_name": "Vasopressin in 0.9% Sodium Chloride", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Vasopressin in 0.9% Sodium Chloride", "active_ingredients": [{"name": "VASOPRESSIN", "strength": "20 [USP'U]/100mL"}], "application_number": "NDA217569", "marketing_category": "NDA", "marketing_start_date": "20230929", "listing_expiration_date": "20261231"}